Pathological changes of hypoplasia or aplasia, hyperplasia with germinal centre formation (dysplasia or thymitis) or thymoma in association with clinical syndromes have been reported since the turn of the century but it was not until the demonstration of the effect of neonatal thymectomy on mice in 1961 (Miller 1961 ) that a sound basis could be attributed for a role of this organ in mammalian physiology and pathophysiology.
Pathological changes of hypoplasia or aplasia, hyperplasia with germinal centre formation (dysplasia or thymitis) or thymoma in association with clinical syndromes have been reported since the turn of the century but it was not until the demonstration of the effect of neonatal thymectomy on mice in 1961 (Miller 1961 ) that a sound basis could be attributed for a role of this organ in mammalian physiology and pathophysiology.
The epithelial thymic rudiment develops mainly from the third branchial cleft, as does the parathyroid rudiment. For its full development the thymus requires the 'inductive' action of mesenchyme and the inflow of stem cells from bone marrow and feetal liver. On maturation, thymusderived (T) lymphocytes are antigen sensitive, forming a recirculating pool of immunologically competent lymphocytes without which the development of cellular immunity does not occur.
T lymphocytes are not themselves capable of secreting immunoglobulin but can act in cooperation with bursa-equivalent (B) lymphocytes, enabling B cells to be triggered more readily by antigen (Playfair 1971) . In addition T lymphocytes have the ability to recognize surface antigens on the viable 'foreign' cells of the same species (homologous) and to transform into cytotoxic lymphocytes capable of killing the target 'foreign' cells in culture (Brunner et al. 1970 ), so providing one important mechanism by which the host can reject homografts and presumably tumour cells.
Experimental studies in animals have suggested at least two possible hormones that may be secreted by the thymus: thymosin, which is connected with the development of immunological competence, and thymin, which is connected with neuromuscular transmission.
CLINICAL CONDMONS IN MAN
Immunological Deficiency Syndromes Deficiencies of the cellular and humoral components of the immunological system occur separately or together. A study of immunological deficiency disorders confirms that the main conclusions drawn from animal experiments are relevant to man. The probable sites of the main developmental defects are shown in Fig 1, but a wide range of immunodeficiency syndromes can occur and may be associated with hypoplasia, aplasia, thymoma or normal thymic histology.
A complete failure of leukocyte stem cell development (Lesion 1) leads to agranulocytosis, severe lymphopenia, thymic hypoplasia and hypoor a-gammaglobulineemia but with normal red blood cells and platelets. A partial defect at this site results in the characteristic pattern of the Swiss type of alymphocytic agammaglobulinmmia in which agranulocytosis is not a feature. Immunological reconstitution with infusions of peripheral lymphocytes and bone marrow cells matched for the HL-A loci from siblings has been described in these conditions (Gatti et al. 1968 , Levey et al. 1971 , Ra'dl et al. 1971 . Further reports on the follow up of these infants, in one case for as long as three years, have shown them to be well and immunologically normal.
Lesions 3, 4 and 5 result in the selective deficiency of T lymphocytes, thymic hypoplasia or aplasia but with normal immunoglobulin levels. The situation is similar to that which develops in neonatally thymectomized mice. As the parathyroids also develop from the third branchial cleft, congenital absence of the parathyroids leads to tetany in the new born (Di George syndrome). Other developmental abnormalities may coexist, e.g. absence of the isthmus of the thyroid and malformations of the heart and aortic arch. Patients present between the ages of 5 weeks and 7 months and are particularly susceptible to fungal infections such as monilia and viral infections such as progressive vaccinia and prolonged varicella. The prognosis for survival of these infants beyond one year of age was very poor until Cleveland et al. (1968) and August et al. (1968) reported the results of grafting feetal human thymus tissue into the abdominal muscles of affected patients. Restoration of cell-mediated immunity was dramatic and the later report by August et al. (1970) demonstrated that normal cell-mediated immunity was still present 18 months after the original operation.
Thymic hypoplasia with lymphopenia and immunoglobulin deficiency may occur as part of the generalized disorder of ataxia telangiectasia (Lesion 6). In a disease characterized by such widespread abnormalities it is difficult to ascertain the basic lesion but, as mentioned above, since mesenchyme has an inductive action in the formation of normal thymus a defect in this tissue could explain the features of this disease. Selective B cell deficiency occurs in the classical sex-linked hypoor a-gammaglobulinemia of Bruton (Lesion 2). Male children alone are involved and the thymic cytoarchitecture is normal and there is no lymphopenia. Patients with this disease can survive a number of years but are susceptible to extracellular pyogenic infections in the form of meningitis, pneumonia and other pulmonary infections. Treatment with injections of immunoglobulin are effective (MRC 1969) .
Some children with persistent mucocutaneous candidiasis have been shown to have deficient cellular immunity and despite antibiotic therapy, adequate serum antibody response and repeated passive administration ofspecific immunoglobulin are unable to eradicate the infection. Leukocytes from a HL-A compatible sibling or a dialysable fraction extracted from peripheral leuokocytes of a candida-sensitive donor (transfer factor, initially described by Lawrence 1969) have been shown to be effective in the treatment of this condition (Valdimarsson, Moss, Holt & Hobbs 1972; Valdimarsson, Wood, Hobbs & Holt 1972) .
Autoimmune Disease
In addition to being involved in the maturation of the immunological system the thymus has also been proposed to have a surveillance function (Bumet 1962) . On this hypothesis, failure of deletion of abnormal clones of immunologically competent lymphocytes, possibly arising within the thymus by spontaneous mutation, may lead to autoimmune disease. Alternatively, loss of peripheral control mechanisms between T and B lymphocytes may result in a similar situation (Allison etal. 1971 ).
Myasthenia Gravis
Only 10% of patients with myasthenia gravis have a normal thymus, 80% have thymic dysplasia with germinal centre formation and plasma cell infiltration, and 10% haveathymoma, usually consisting predominantly of large pale epithelial cells. The histological appearances of the germinal centre formation and its resemblance to the thyroid in Hashimoto's thyroiditis first prompted the suggestion by Smithers (1959) that myasthenia gravis may have an autoimmune origin. Goldstein (1966) proposed that the basic lesion in the thymus in myasthenia gravis was chronic inflammation, drawing a parallel with the histological appearances of chronic inflammation at other sites. This lesion is preferably referred to as thymitis or dysplasia rather than hyperplasia, as it does seem to be an autoimmune reaction against an antigenic component of the thymus. Those patients with thymoma generally have thymitis in the surrounding tissue.
The hypothesis that thymitis is the initial lesion in the development of myasthenia gravis is based on the following evidence. The serum of about 40% of all patients with myasthenia gravis has a circulating antibody cross-reacting with myoid cells of the thymic medulla and the I bands of skeletal muscle (Strauss & Kemp 1967) . The incidence is 95% in patients with myasthenia gravis associated with thymoma. In addition Strauss et al. (1966) found that 12 of 51 patients with thymoma unassociated with myasthenia gravis had a high titre of these antibodies. While myoid antibody probably has no direct effect on neuromuscular transmission it may be regarded as indicating an autoimmune reaction against the thymus. Recently Kornguth et al. (1970) reported antineuronal antibodies in the sera of patients with myasthenia gravis which may have pathogenic significance.
Section ofRadiology
An autoimmune reaction to myoid cells in thymomas may result in the production of myoid autoantibody and a cellular reaction within the thymus results in the lesion of thymitis. The initiating factor in those patients with thymitis alone is not known. The fact that there is a clinical and serological overlap between myasthenia gravis and other diseases ofan autoimmune nature, e.g. thyrotoxicosis, pernicious anemia, rheumatoid arthritis, &c., suggests a common etiological lesion (Simpson 1958) , such as a disorder of immunological tolerance.
If myasthenia gravis is an autoimmune disease of which thymitis is the basic lesion it should be possible to induce a similar state in experimental animals which should show features of thymitis, muscle and thymus myoid cell antibodies and the characteristic type of neuromuscular block. Goldstein & Whittingham (1966 and Kalden et al. (1970) have shown that it is possible in guinea-pigs and rats to produce an experimental model of myasthenia gravis by immunization with skeletal and thymic extracts together with Freund's adjuvant via the foot-pads. The majority of the animals so immunized have marked lymphocytic infiltration in the thymic medulla around Hassall's corpuscles and develop circulating autoantibody which reacts with skeletal and cardiac muscle striations and with the myoid cells of the thymus. Control animals injected with lymph node extract or saline in Freund's adjuvant showed little or none of these changes.
Evidence for a defect in neuromuscular transmission was sought. In immunized animals with thymitis there was a rapid decline in muscle action potentials following tetanic supramaximal nerve stimulation, similar to that observed in patients with myasthenia gravis. In control animals and normal patients such stimulation produced no decline in the action potential. Goldstein & Hofmann (1968) have further shown that miniature end-plate potentials are significantly reduced in immunized animals in keeping with the clinical state in man. Goldstein & Hofmann (1969) have also produced evidence that the thymus in experimental animals secretes a humoral substance, thymin, which affects neuromuscular transmission and which is released in excess when thymitis is present. Its effect is to produce a neuromuscular block similar to that present in cases of myasthenia gravis. It has not yet been detected in man.
There is no doubt that in selected cases of myasthenia gravis thymectomy is of benefit. The results of operation have been best in young females who have suffered from the disease for less than five years. Patients with thymoma have a poorer response to thymectomy and a poorer long-term prognosis. The fact that a proportion do not respond could be explained on the basis of irreversible damage at the neuromuscular junction or incomplete thymectomy, as 20% of thymic tissue is ectopic in position.
Thyroid Autoimmune Disease
At post-mortem germinal centre formation has been noted in the thymus medulla, particularly in thyrotoxicosis. The thymus in thyroid disease has been studied by thymic biopsy obtained during the course of partial thyroidectomy (Gunn et al. 1964) . A correlation was noted between the presence ofgerminal centres in the thymic medulla and the presence of germinal centres in the thyroid. This correlation was well marked in cases of thyrotoxicosis. Radiological assessment of the thymus (Irvine & Summerling 1965) indicated that the larger thymic shadows were present in those cases that had thyroid and gastric autoantibodies in their serum. As an X-ray does not indicate how much of the thymic shadow is connective tissue and how much is thymic tissue, Michie et al. (1967) hoped to get a more valid assessment of the thymus by calculating 'corrected thymus size'. This is the product of the radiological measurement of thymus size and the percentage of thymic parenchyma in a biopsy of the thymus. Corrected thymic size was found to be larger in cases of thyrotoxicosis and smaller in most cases of Hashimoto's thyroiditis than in non-toxic nodular goitre. The larger corrected thymic size in thyrotoxicosis was strongly correlated with the presence of thyroid autoantibodies. Thymic germinal centres were noted in 50% of cases of thyrotoxicosis and in only 7 % of cases of Hashimoto's thyroiditis; Michie et al. (1967) considered that thymic germinal centres in thyroid disease are related to raised thyroxine levels rather than autoimmunity per se, but this has been disputed.
OTHER AUTOIMMUNE DISEASES
In Addison's disease, increased lymphocytic infiltration has been noted in the thymic medulla but no distinction has been made between cases of idiopathic (autoimmune) Addison's disease and those with tuberculous destruction of the adrenal glands.
Thymic changes have been noted in systemic lupus erythematosus. Germinal centre formation may occur but the most constant feature is the presence of spindle-epithelial cells, plasma cells and numerous cystic Hassall's corpuscles. Some of these changes may be due to stress but findings consistent with an immunological reaction are present. Thymectomy has not as yet been shown to be of any benefit in these cases.
Mice of the NZB strain that develop autoimmune hemolytic ancmia spontaneously have a high incidence of germinal centre formation in the thymus. There is evidence that the auto-immune disease in these mice is induced by a vertically transmitted virus. It is possible to delay the development of the hlemolytic anemia by injection of thymocytes from young NZB mice, suggesting that the virus may induce changes in the normal peripheral control mechanisms between the T and B lymphocytes in initiating this disease (Allison et al. 1971) . Two cases of autoimmune haemolytic anaemia in man have been reported which responded to thymectomy when all other forms of treatment failed. In one case in the thymus there was marked stress involution, in the other plasma cell infiltration. It may be that therapy in the form of transfer factor from normal donors could be of value in this conditon.
THYMOMA AND CLINICAL SYNDROMES
Myasthenia gravis: The association of thymoma and myasthenia gravis has been described above. Erythroid hypoplasia: Fifty per cent of cases of red blood cell aplasia have an associated thymoma. It is possible that the thymoma produces a substance which selectively depresses the production of red blood cells. This is suggested by the occasional benefit of thymectomy (Kaung et al. 1968 ) and by recent reports of the demonstration of an erythropoiesis inhibitory substance present in the serum of such patients (Al-Mondhiry et al. 1971). Hypogammaglobulinwmia: Ten per cent of cases of hypogammaglobulinwmia have an associated thymoma. In one series (Jeunet & Good 1968 ) 6 out of 7 cases had evidence of depressed cellular immunity. The relationship between the thymus and this disease is not clear. CANCER Considerable evidence is being accumulated from animal studies indicating a causal relationship between immunological competence, especially of thymic dependent nature, and neoplasms induced by viruses, chemicals or radiation. Early studies by Furth (1946) showed that thymectomy in young mice of a high leukemic strain significantly lowered the incidence of spontaneous lymphocytic leukemia. Further studies indicated that the presence or absence of the thymus markedly influenced the incidence of tumour formation following a viral challenge or subsequent to whole body X-irradiation. Patients with immunological deficiency diseases have a high incidence of neoplasm especially of the lymphoreticular type, as do patients receiving immunosuppressive therapy following organ transplantation. Souadjian et al. (1968) reported that the incidence of non-thymic neoplasm in patients followed for as long as twenty years after operation for thymoma was significantly higher than in a similar group who had had a parathyroidectomy, i.e. 21 % compared with 8 %.
There is evidence that there is marked depression of cellular immunity in cases of carcinoma of various types. Whether the thymus can be implicated in the pathogenesis of these forms of carcinoma is conjecture at this point.
In conclusion, the central role of the thymus in the development of the immunological system has been demonstrated in small laboratory animals. Evidence of its role in clinical medicine in the etiology of disease is now becoming clearer.
